Revance Therapeutics Inc (RVNC)

Oct 30, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RVNC, CPTN, RCM on Behalf of Shareholders - Stockhouse Publishing

Oct 30, 2024

Oct 29, 2024

Revance Therapeutics revises Teoxane agreement, expands distribution to ANZ By Investing.com - Investing.com Canada

Oct 29, 2024

Oct 28, 2024

Traders Buy High Volume of Put Options on Revance Therapeutics (NASDAQ:RVNC) - MarketBeat

Oct 28, 2024

Oct 28, 2024

Revance Therapeutics' (RVNC) "Hold" Rating Reaffirmed at Needham & Company LLC - MarketBeat

Oct 28, 2024

Oct 28, 2024

Revance Therapeutics revises Teoxane agreement, expands distribution to ANZ - Investing.com

Oct 28, 2024

Oct 28, 2024

Revance Therapeutics (NASDAQ:RVNC) Shares Gap UpHere's What Happened - MarketBeat

Oct 28, 2024

Oct 28, 2024

Crown Settles Customer Dispute To Close $924M Revance Buy - Law360

Oct 28, 2024

Oct 28, 2024

PROCEPT BioRobotics Posts Strong Q3 Earnings, Joins Monte Rosa Therapeutics, EyePoint Pharmaceuticals And Other Big Stocks Moving Higher On Monday - Benzinga

Oct 28, 2024

Oct 28, 2024

“Top Biotech Opportunities: RVNC, HCTI, GLUE, PRSO, CRDL, Showing Promising Developments” - Barchart

Oct 28, 2024

Oct 28, 2024

Revance Therapeutics surges after Crown tender offer extended, settles with Teoxane - MSN

Oct 28, 2024

Oct 28, 2024

Revance Shares Rise Premarket on Teoxane Settlement, Tender Extension - MarketWatch

Oct 28, 2024

Oct 28, 2024

Revance Therapeutics, Inc. and Teoxane SA Enters into the Sixth Amendment to the Exclusive Distribution Agreement - Marketscreener.com

Oct 28, 2024

Oct 26, 2024

Revance Therapeutics drops as deadline for Crown Lab tender set to expire - MSN

Oct 26, 2024

Oct 25, 2024

Revance Therapeutics (NASDAQ:RVNC) Shares Down 3.8%Should You Sell? - MarketBeat

Oct 25, 2024

Oct 25, 2024

StockNews.com Begins Coverage on Revance Therapeutics (NASDAQ:RVNC) - MarketBeat

Oct 25, 2024

Oct 19, 2024

Revance Therapeutics extends merger offer date amid Teoxane talks - Investing.com India

Oct 19, 2024

Oct 18, 2024

Revance Therapeutics extends merger offer date amid Teoxane talks By Investing.com - Investing.com Australia

Oct 18, 2024

Oct 18, 2024

Revance Therapeutics, Crown Labs Again Extend Tender Offer Deadline - MarketWatch

Oct 18, 2024

Oct 18, 2024

Revance Therapeutics, Inc. (NASDAQ:RVNC) Receives Consensus Rating of "Hold" from Analysts - MarketBeat

Oct 18, 2024

Oct 17, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Revance Therapeutics, Inc.RVNC - PR Newswire

Oct 17, 2024

Oct 17, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates K, RVNC, CPTN on Behalf of Shareholders - GlobeNewswire Inc.

Oct 17, 2024

Oct 17, 2024

The Law Offices of Frank R. Cruz Announces Investigation of Revance Therapeutics, Inc. (RVNC) on Behalf of Investors - Business Wire

Oct 17, 2024

Oct 17, 2024

(RVNC) Trading Signals - Stock Traders Daily

Oct 17, 2024

Oct 17, 2024

StockNews.com Initiates Coverage on Revance Therapeutics (NASDAQ:RVNC) - MarketBeat

Oct 17, 2024

Oct 15, 2024

Law Offices of Howard G. Smith Announces Investigation of Revance Therapeutics, Inc. (RVNC) on Behalf of Investors - Marketscreener.com

Oct 15, 2024

Oct 15, 2024

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Revance Therapeutics, Inc. (RVNC) on Behalf of Investors - Business Wire

Oct 15, 2024

Oct 15, 2024

Revance Therapeutics, Inc. (NASDAQ:RVNC) Short Interest Up 25.0% in September - MarketBeat

Oct 15, 2024

Oct 15, 2024

AQR Capital Management LLC Has $517,000 Stake in Revance Therapeutics, Inc. (NASDAQ:RVNC) - MarketBeat

Oct 15, 2024

Oct 13, 2024

Algert Global LLC Sells 127,260 Shares of Revance Therapeutics, Inc. (NASDAQ:RVNC) - MarketBeat

Oct 13, 2024

Oct 09, 2024

Revance Therapeutics (NASDAQ:RVNC) Coverage Initiated at StockNews.com - MarketBeat

Oct 09, 2024

Oct 07, 2024

(RVNC) Investment Report - Stock Traders Daily

Oct 07, 2024

Oct 05, 2024

Revance Therapeutics, Crown Labs tender offer extended until Oct. 18 - MSN

Oct 05, 2024

Oct 05, 2024

Renaissance Technologies LLC Acquires 198,300 Shares of Revance Therapeutics, Inc. (NASDAQ:RVNC) - MarketBeat

Oct 05, 2024

Oct 04, 2024

Revance Therapeutics extends tender offer amid Teoxane dispute - Investing.com

Oct 04, 2024

Oct 04, 2024

Revance Therapeutics merger delayed due to alleged contract breach - The Business Journals

Oct 04, 2024

Oct 04, 2024

Revance Therapeutics (NASDAQ:RVNC) Shares Down 4.6%Should You Sell? - MarketBeat

Oct 04, 2024

Oct 04, 2024

William Blair Downgrades Revance Therapeutics (RVNC) - MSN

Oct 04, 2024

Oct 04, 2024

Revance Therapeutics extends tender offer amid Teoxane dispute By Investing.com - Investing.com UK

Oct 04, 2024

Oct 04, 2024

Revance Therapeutics, Crown Labs Extend Tender Offer Start Deadline to Oct. 18 >RVNC - MarketWatch

Oct 04, 2024

Oct 03, 2024

Revance Therapeutics falls as Crown Labs didn't start tender offer by deadline (update) - MSN

Oct 03, 2024

Oct 01, 2024

Revance Therapeutics (NASDAQ:RVNC) Shares Gap Down to $5.36 - MarketBeat

Oct 01, 2024

Oct 01, 2024

Revance Therapeutics, Inc. (NASDAQ:RVNC) is Stonepine Capital Management LLC's 5th Largest Position - MarketBeat

Oct 01, 2024

Sep 30, 2024

Revance Therapeutics' SWOT analysis: tender offer shakes up aesthetics stock - Investing.com

Sep 30, 2024

Sep 28, 2024

Down -17.96% in 4 Weeks, Here's Why Revance Therapeutics (RVNC) Looks Ripe for a Turnaround - MSN

Sep 28, 2024

Sep 27, 2024

Kuehn Law Encourages RVNC, RFL, BTTR, and ARC Investors to Contact Law Firm - The Malaysian Reserve

Sep 27, 2024

Sep 26, 2024

Revance Therapeutics: Crown Merger Red Flags Makes For Problematic Call On Shares (RVNC) - Seeking Alpha

Sep 26, 2024

Sep 26, 2024

When (RVNC) Moves Investors should Listen - Stock Traders Daily

Sep 26, 2024

Sep 26, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RVNC, GATO, RFL on Behalf of Shareholders - Longview News-Journal

Sep 26, 2024